Bojana Zegura

Dr. Bojana Zegura

National Institute of Biology, Department of Genetic Toxicology and Cancer Biology
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
ACAndrew Collins
Andrew Collins
PMPETER MOLLER
PETER MOLLER
Goran GajskiGoran Gajski
Goran Gajski
SVSoňa Vodenková
Soňa Vodenková
AAAbdulhadi Abdulwahed
Abdulhadi Abdulwahed
Amaya AzquetaAmaya Azqueta
Amaya Azqueta

26 October 2020 in Nature Protocols
Verified
Journal Article
Open access
PDF file
PMPETER MOLLER
PETER MOLLER
Amaya AzquetaAmaya Azqueta
Amaya Azqueta
EBElisa Boutet-Robinet
Elisa Boutet-Robinet
GKGudrun Koppen
Gudrun Koppen
Stefano BonassiStefano Bonassi
Stefano Bonassi
SLSabine A. S. Langie
Sabine A. S. Langie
The comet assay is a widely used test for the detection of DNA damage and repair activity. However, there are interlaboratory differences in reported levels of baseline and induced damage in the same experimental systems. These differences may be attributed to protocol differences, although it is difficult to identify the relevant conditions because detailed comet assay procedures are not always published. Here, we present a Consensus Statement for the Minimum Information for Reporting Comet Assay (MIRCA) providing recommendations for describing comet assay conditions and results. These recommendations differentiate between ‘desirable’ and ‘essential’ information: ‘essential’ information refers to the precise details that are necessary to assess the quality of the experimental work, whereas ‘desirable’ information relates to technical issues that might be encountered when repeating the experiments. Adherence to MIRCA recommendations should ensure that comet assay results can be easily interpreted and independently verified by other researchers.

1 January 2011 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
Bojana ZeguraBojana Zegura
Bojana Zegura
AŠAlja Štern
Alja Štern
MFMetka Filipič
Metka Filipič

17 September 2010 in Nanotoxicology
Verified
Journal Article
Open access
JPJana PetkoviĆ
Jana PetkoviĆ
Bojana ZeguraBojana Zegura
Bojana Zegura
Magdalena StevanovićMagdalena Stevanović
Magdalena Stevanović
NDNataša Drnovšek
Nataša Drnovšek
DUDragan UskokoviĆ
Dragan UskokoviĆ
MFMetka FilipiČ
Metka FilipiČ
We investigated the genotoxic responses to two types of TiO2 nanoparticles (<25 nm anatase: TiO(2)-An, and <100 nm rutile: TiO2-Ru) in human hepatoma HepG2 cells. Under the applied exposure conditions the particles were agglomerated or aggregated with the size of agglomerates and aggregates in the micrometer range, and were not cytotoxic. TiO2-An, but not TiO2-Ru, caused a persistent increase in DNA strand breaks (comet assay) and oxidized purines (Fpg-comet). TiO2-An was a stronger inducer of intracellular reactive oxygen species (ROS) than TiO2-Ru. Both types of TiO2 nanoparticles transiently upregulated mRNA expression of p53 and its downstream regulated DNA damage responsive genes (mdm2, gadd45α, p21), providing additional evidence that TiO2 nanoparticles are genotoxic. The observed differences in responses of HepG2 cells to exposure to anatase and rutile TiO2 nanoparticles support the evidence that the toxic potential of TiO2 nanoparticles varies not only with particle size but also with crystalline structure.

1 January 2003 in Toxicon
Verified
Journal Article
Closed access
Bojana ZeguraBojana Zegura
Bojana Zegura
BSBojan Sedmak
Bojan Sedmak
MFMetka Filipič
Metka Filipič

1 December 2016 in Environmental Pollution
Verified
Journal Article
Closed access
Marina IsidoriMarina Isidori
Marina Isidori
Margherita LavorgnaMargherita Lavorgna
Margherita Lavorgna
CRChiara Russo
Chiara Russo
Michael KundiMichael Kundi
Michael Kundi
Bojana ZeguraBojana Zegura
Bojana Zegura
EHEster Heath
Ester Heath